NOVEL PSEUDOSYMMETRIC INHIBITORS OF HIV-1 PROTEASE

被引:12
|
作者
FASSLER, A
ROSEL, J
GRUTTER, M
TINTELNOTBLOMLEY, M
ALTERI, E
BOLD, G
LANG, M
机构
[1] Research Laboratories, Pharmaceutical Division, Ciba-Geigy Ltd.
关键词
D O I
10.1016/S0960-894X(01)80775-7
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Compounds containing the easily accessible Phe[CH(OH)CH2N(NH)]Phe dipeptide isostere as a non-hydrolyzable replacement of the scissile amide bond in the natural substrate are potent inhibitors of HIV-1 protease. The expected symmetric binding pattern of the most potent inhibitor in this series (CGP 53820, IC50 = 9 nM) is illustrated by the X-ray analysis performed with the corresponding enzyme-inhibitor complex.
引用
收藏
页码:2837 / 2842
页数:6
相关论文
共 50 条
  • [31] Toward the synthesis of novel boronates as potential HIV-1 protease inhibitors
    Contreras, Erik M.
    Sigurjonsson, Kristin
    Frank, Michael D.
    Treich, Nicholas
    Fabry-Asztalos, Levente
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [32] Novel HIV-1 protease inhibitors: Design, synthesis, and biological evaluation
    Osswald, Heather
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [33] A CONVERGENT SYNTHESIS NOVEL CONFORMATIONALLY RESTRICTED HIV-1 PROTEASE INHIBITORS
    KIM, BM
    GUARE, JP
    HANIFIN, CM
    ARFORDBICKERSTAFF, DJ
    VACCA, JP
    BALL, RG
    TETRAHEDRON LETTERS, 1994, 35 (29) : 5153 - 5156
  • [34] Towards the synthesis of novel boronates as potential HIV-1 protease inhibitors
    Nye, Jesse L.
    Clayton, Donald R.
    McCammant, Matt S.
    Fabry-Asztalos, Levente
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [35] Ionic derivatives of betulinic acid as novel HIV-1 protease inhibitors
    Zhao, Hua
    Holmes, Shaletha S.
    Baker, Gary A.
    Challa, Suresh
    Bose, Himangshu S.
    Song, Zhiyan
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2012, 27 (05) : 715 - 721
  • [36] Towards the synthesis of novel boronates as potential HIV-1 protease inhibitors
    Schreiber, John D.
    Faulkner, Andrea L.
    Holmberg, Leah L.
    Jennings, Julia J.
    Frank, Michael D.
    Nye, Jesse L.
    Clayton, Donald R.
    Fabry-Asztalos, Levente
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [37] Fat accumulation and HIV-1 protease inhibitors
    Stricker, RB
    Goldberg, B
    LANCET, 1998, 352 (9137): : 1392 - 1392
  • [38] The Triple Threat of HIV-1 Protease Inhibitors
    Potempa, Marc
    Lee, Sook-Kyung
    Wolfenden, Richard
    Swanstrom, Ronald
    FUTURE OF HIV-1 THERAPEUTICS: RESISTANCE IS FUTILE?, 2015, 389 : 203 - 241
  • [39] HIV-1 protease inhibitors and drug interactions
    Welch, S
    ADDICTION, 1997, 92 (07) : 905 - 905
  • [40] NONPEPTIDE COMPETITIVE INHIBITORS OF HIV-1 PROTEASE
    TUMMINO, PJ
    FERGUSON, D
    HUPE, L
    TAIT, B
    HUPE, D
    FASEB JOURNAL, 1994, 8 (07): : A1373 - A1373